Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, unpicks the current small molecule funding landscape, how to improve incentives to invest in rare diseases and more.

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Isabel is joined by Tim Uden, Creative Director, EMJ to discuss the new frontier of medical education tools and skills – interactive content.

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.

Mercedes Diz, Chief Marketing Officer, Almirall, talks about pushing your limits to achieve your goals and how to be more patient centric.

This special episode features three of last year’s guests, who share their predictions for the pharmaceutical industry’s year ahead.

Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals.